KARA BEASLEY: Open Payments
NPI 1437935665 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,127 in 57 payments from 11 companies in 2025. Trend: 2023 $41 · 2024 $453 · 2025 $1,127
Food & beverage: $1,127
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 14 | $252 |
| ABBVIE INC. | 14 | $191 |
| Axsome Therapeutics, Inc. | 8 | $156 |
| Otsuka America Pharmaceutical, Inc. | 7 | $142 |
| Janssen Pharmaceuticals, Inc | 2 | $140 |
| Lundbeck LLC | 3 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $58 |
| Alkermes, Inc. | 2 | $46 |
| Noven Therapeutics, LLC | 2 | $32 |
| Tris Pharma Inc | 1 | $18 |
Products named: REXULTI, VRAYLAR, Auvelity, FANAPT, SPRAVATO, HETLIOZ, TRINTELLIX, ARISTADA.
Industry payments across TN — which companies pay providers there.
